Myeloperoxidase, a Leukocyte-Derived Vascular NO Oxidase
Citations Over TimeTop 1% of 2002 papers
Abstract
Myeloperoxidase (MPO) is an abundant mammalian phagocyte hemoprotein thought to primarily mediate host defense reactions. Although its microbicidal functions are well established in vitro, humans deficient in MPO are not at unusual risk of infection. MPO was observed herein to modulate the vascular signaling and vasodilatory functions of nitric oxide (NO) during acute inflammation. After leukocyte degranulation, MPO localized in and around vascular endothelial cells in a rodent model of acute endotoxemia and impaired endothelium-dependent relaxant responses, to which MPO-deficient mice were resistant. Altered vascular responsiveness was due to catalytic consumption of NO by substrate radicals generated by MPO. Thus MPO can directly modulate vascular inflammatory responses by regulating NO bioavailability.
Related Papers
- → Regulation of Superoxide Anion Production by NADPH Oxidase in Monocytes/Macrophages(2003)362 cited
- → A myeloperoxidase precursor, pro-myeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients(2018)24 cited
- → Effect of three polychlorinated biphenyls on f-met-leu-phe-induced degranulation in rat neutrophils(1998)9 cited
- Studies on the Specific Degranulation of Mast Cell Sensitized by Several Allergens in vitro(2009)
- → Studies on the degranulation of rat mesentery mast cells induced by a toxic substance from the sea urchin Toxopneustes pileolus.(1983)